Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #351 to #400.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Glypican 3 (2 links)
  2. Golimumab (2 links)
  3. Gomiliximab (2 links)
  4. Graft-versus-host disease (2 links)
  5. Graft versus host disease (2 links)
  6. Gram-negative (2 links)
  7. Growth differentiation factor (2 links)
  8. Growth differentiation factor 8 (2 links)
  9. Guanylate cyclase 2C (2 links)
  10. Guselkumab (2 links)
  11. HER1 (2 links)
  12. HER2/neu (2 links)
  13. HER3 (2 links)
  14. HHGFR (2 links)
  15. HIV-1 (2 links)
  16. HIV infection (2 links)
  17. HLA-DR (2 links)
  18. Haemophilia A (2 links)
  19. Haemorrhagic shock (2 links)
  20. Head and neck cancer (2 links)
  21. Heart attack (2 links)
  22. Hemagglutinin (influenza) (2 links)
  23. Hemagglutinin HA (2 links)
  24. Hematological cancer (2 links)
  25. Hemolytic disease of the newborn (2 links)
  26. Hepatitis B (2 links)
  27. Hepatocyte growth factor (2 links)
  28. Hodgkin's lymphoma (2 links)
  29. Hsp90 (2 links)
  30. Hypercholesterolemia (2 links)
  31. ICAM-1 (2 links)
  32. IFN-γ (2 links)
  33. IGHE (2 links)
  34. IL-1β (2 links)
  35. IL-6 receptor (2 links)
  36. IL17A (2 links)
  37. IL17F (2 links)
  38. IL1A (2 links)
  39. IL23A (2 links)
  40. IL31RA (2 links)
  41. IMAB362 (2 links)
  42. ITGA2 (2 links)
  43. ITGB2 (2 links)
  44. Ibalizumab (2 links)
  45. Ibritumomab tiuxetan (2 links)
  46. Icrucumab (2 links)
  47. Idarucizumab (2 links)
  48. Idiopathic pulmonary fibrosis (2 links)
  49. IgE (2 links)
  50. IgE receptor (2 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://eln.excellgen.com/index.php?title=Special:MostLinkedPages"